The primary outcome was analyzed using a linear regression model, adjusted for baseline weight, type of surgery, sex and diabetes status, according to the ITT principle
Follow their advice even if it differs from what you read online or hear from others
AbbVie completed the acquisition on August 19, 2025
The GLP-1 stall, that maddening stretch where semaglutide stops producing results , where tirzepatide seems to quit working , where your body appears to dig in its heels against every milligram of medication, is one of the most common and most misunderstood phases of GLP-1 therapy
is growing as more people seek effective weight management solutions
Whether its due to side effects, insurance coverage, or treatment goals, making a transition between semaglutide and tirzepatide requires careful planning and clinical supervision